Efficacy and safety of retreatment with infliximab after withdrawal under immunosuppressant. A subanalysis of the stori study.

E Louis, G Vernier-Massouille, JC Grimaud, Y Bouhnik, D Laharie, JL Dupas, H Pillant, L Picon, M Veyrac, M Flamant, G Savoye, R Jian, M De Vos, G Paintaud, E Piver, JY Mary, JF Colombe, M Lémann

–